Exceptional cultural insight to accelerate Japanese market entry
Partner with Aurora Clinical to confidently navigate the opportunities and complexities of the Japanese market.
Welcome to Aurora Clinical
Aurora Clinical supports emerging biopharma navigating Japan’s dynamic regulatory and clinical development landscape. At Aurora Clinical, we cross language, cultural and medical practice barriers by combining deep regulatory expertise, innovative clinical solutions, and exceptional cultural insight to accelerate Japanese market entry – the world’s third largest single pharmaceutical market.
Our Services
In-Country Clinical Caretaker (ICCC) Services
Act as a local representative, supporting companies without a physical presence in Japan.
Regulatory and Development Strategy
Navigating Japan’s regulatory environment requires expertise and local insight. Aurora Clinical offers comprehensive regulatory consultation services
Strategic Key Opinion Leader Engagement and Asset Awareness
We facilitate targeted engagement with influential Key Opinion Leaders (KOLs) in Japan to maximize awareness and credibility of clients’ assets.
Pharmacovigilance
Our pharmacovigilance services ensure continuous safety monitoring and compliance with local regulatory requirements.
Market Analysis and Pricing
Facilitation and Negotiation with Japanese Licensing Partners
Also, through Aurora Partners, we can support international companies in identifying, engaging, and negotiating with suitable Japanese partners.
Through our partnership with Aurora Partners we can also offer:
Market Entry analysis and support
Identification and negotiation with Japanese partners for partnership creation including R&D collaboration, distribution, licensing, JVs, M&A agreements
Market Research and Reimbursement Pricing Analysis and support